國立高雄大學圖資館 |

Anhedoniapreclinical, translational, and clinical integration /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Anhedoniaedited by Diego A. Pizzagalli.
Reminder of title:	preclinical, translational, and clinical integration /
other author:	Pizzagalli, Diego A.
Published:	Cham :Springer International Publishing :2022.
Description:	xi, 535 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Anhedonia.
Online resource:	https://doi.org/10.1007/978-3-031-09683-9
ISBN:	9783031096839$q(electronic bk.)

Anhedoniapreclinical, translational, and clinical integration /
Anhedoniapreclinical, translational, and clinical integration /[electronic resource] :edited by Diego A. Pizzagalli. - Cham :Springer International Publishing :2022. - xi, 535 p. :ill., digital ;24 cm. - Current topics in behavioral neurosciences,v. 581866-3389 ;. - Current topics in behavioral neurosciences ;9..

Section I. Anhedonia - History, Etiology, and Assessments -- 1. Historical Perspective -- 2. Clinical and Behavioral Assessments -- 3. Developmental Trajectories: Preclinical -- 4. Developmental Trajectories: Clinical -- 5. Genetics Contributions -- 6. Environmental Contributions -- Section II. Anhedonia in Psychiatric and Neurological Disorders -- 7. Depression and Bipolar Disorder -- 8. Schizophrenia -- 9. Substance Use Disorder -- 10. Nicotine Dependence -- 11. Posttraumatic Stress Disorder -- 12. Anxiety -- 13. Eating Disorders -- 14. Autism and Developmental Disorders -- 15. Neurodegenerative Disorders -- Section III. Reward Processing Systems in Anhedonia -- Reward Responsiveness -- 16. Pleasure -- 17. Anticipation -- Reward Valuation -- 18. Reward Value - Delay and Reward Magnitude -- 19. Effort/Motivation -- Reward Learning -- 20. Reward Prediction Error -- 21. Probabilistic and Reinforcement Learning -- Section IV. Treatments -- 22. Pharmacological Treatments for Anhedonia -- 23. Psychological Treatments for Anhedonia -- 24. Neurostimulation -- Section V. Special Topics -- 25. Inflammation and Anhedonia -- 26. Computational Modeling of Anhedonia -- 27. Anhedonia and Suicide.

Anhedonia is a key symptom (and often risk factor) for various neuropsychiatric disorders, including depression, schizophrenia, substance use disorders, post-traumatic stress disorders, and Parkinson's Disease, among others. Across disorders, anhedonia has been associated with worse disease course, including poor response to pharmacological, psychological and neurostimulation treatments as well as completed suicide. Mounting evidence emerging from preclinical and translational sciences has clarified that "anhedonia" can be parsed into partially independent subcomponents, including incentive motivation, consummatory pleasure, reward learning, and effort-based decision making, pointing to distinct neurobiological substrates that could underlie anhedonic phenotypes. Taking an integrative approach that emphasizes cross-species integration and dimensional conceptualization of mental illnesses (e.g., Research Domain Criteria (RDoC)), this book represents the most comprehensive evaluation, synthesis and integration of theories and empirical findings focused on anhedonia. Organized across five parts, the handbook starts with chapters on the history, etiology, and assessments of anhedonia (Part I), followed by a section on the role of anhedonia in psychiatric and neurological disorders (Part II) Using the RDoC Matrix as a guide, Part III presents chapters synthetizing preclinical and clinical findings on different reward processing subdomains (e.g., reward responsiveness, reward valuation, reward learning) Part IV is focused on selected special topics, including historical and current perspectives on the transdiagnostic nature and importance of social anhedonia, the role of inflammation in the pathophysiology of anhedonia, the use of computational modeling to "dissect" anhedonia and improve its understanding, and links between anhedonia and suicide. Finally, Part V includes chapters on pharmacological, psychological and neurostimulation treatments for anhedonia.

ISBN: 9783031096839$q(electronic bk.)

Standard No.: 10.1007/978-3-031-09683-9doiSubjects--Topical Terms:

933152
Anhedonia.

LC Class. No.: RC541 / .A54 2022

Dewey Class. No.: 616.89

Anhedoniapreclinical, translational, and clinical integration /
LDR:04243nmm a2200325 a 4500 001 628752
003 DE-He213
005 20220808203626.0
007 cr nn 008maaau
008 230224s2022 sz s 0 eng d
020 $a 9783031096839$q(electronic bk.)
020 $a 9783031096822$q(paper)
024 7 $a 10.1007/978-3-031-09683-9 $2 doi
035 $a 978-3-031-09683-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC541 $b .A54 2022
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 616.89 $2 23
090 $a RC541 $b .A596 2022
245 0 0 $a Anhedonia $h [electronic resource] : $b preclinical, translational, and clinical integration / $c edited by Diego A. Pizzagalli.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xi, 535 p. : $b ill., digital ; $c 24 cm.
490 1 $a Current topics in behavioral neurosciences, $x 1866-3389 ; $v v. 58
505 0 $a Section I. Anhedonia - History, Etiology, and Assessments -- 1. Historical Perspective -- 2. Clinical and Behavioral Assessments -- 3. Developmental Trajectories: Preclinical -- 4. Developmental Trajectories: Clinical -- 5. Genetics Contributions -- 6. Environmental Contributions -- Section II. Anhedonia in Psychiatric and Neurological Disorders -- 7. Depression and Bipolar Disorder -- 8. Schizophrenia -- 9. Substance Use Disorder -- 10. Nicotine Dependence -- 11. Posttraumatic Stress Disorder -- 12. Anxiety -- 13. Eating Disorders -- 14. Autism and Developmental Disorders -- 15. Neurodegenerative Disorders -- Section III. Reward Processing Systems in Anhedonia -- Reward Responsiveness -- 16. Pleasure -- 17. Anticipation -- Reward Valuation -- 18. Reward Value - Delay and Reward Magnitude -- 19. Effort/Motivation -- Reward Learning -- 20. Reward Prediction Error -- 21. Probabilistic and Reinforcement Learning -- Section IV. Treatments -- 22. Pharmacological Treatments for Anhedonia -- 23. Psychological Treatments for Anhedonia -- 24. Neurostimulation -- Section V. Special Topics -- 25. Inflammation and Anhedonia -- 26. Computational Modeling of Anhedonia -- 27. Anhedonia and Suicide.
520 $a Anhedonia is a key symptom (and often risk factor) for various neuropsychiatric disorders, including depression, schizophrenia, substance use disorders, post-traumatic stress disorders, and Parkinson's Disease, among others. Across disorders, anhedonia has been associated with worse disease course, including poor response to pharmacological, psychological and neurostimulation treatments as well as completed suicide. Mounting evidence emerging from preclinical and translational sciences has clarified that "anhedonia" can be parsed into partially independent subcomponents, including incentive motivation, consummatory pleasure, reward learning, and effort-based decision making, pointing to distinct neurobiological substrates that could underlie anhedonic phenotypes. Taking an integrative approach that emphasizes cross-species integration and dimensional conceptualization of mental illnesses (e.g., Research Domain Criteria (RDoC)), this book represents the most comprehensive evaluation, synthesis and integration of theories and empirical findings focused on anhedonia. Organized across five parts, the handbook starts with chapters on the history, etiology, and assessments of anhedonia (Part I), followed by a section on the role of anhedonia in psychiatric and neurological disorders (Part II) Using the RDoC Matrix as a guide, Part III presents chapters synthetizing preclinical and clinical findings on different reward processing subdomains (e.g., reward responsiveness, reward valuation, reward learning) Part IV is focused on selected special topics, including historical and current perspectives on the transdiagnostic nature and importance of social anhedonia, the role of inflammation in the pathophysiology of anhedonia, the use of computational modeling to "dissect" anhedonia and improve its understanding, and links between anhedonia and suicide. Finally, Part V includes chapters on pharmacological, psychological and neurostimulation treatments for anhedonia.
650 0 $a Anhedonia. $3 933152
650 1 4 $a Neuroscience. $3 297547
650 2 4 $a Psychiatry. $3 201470
700 1 $a Pizzagalli, Diego A. $3 933151
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Current topics in behavioral neurosciences ; $v 9. $3 559431
856 4 0 $u https://doi.org/10.1007/978-3-031-09683-9
950 $a Biomedical and Life Sciences (SpringerNature-11642)